Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and Bone Cancer

resveratrol has been researched along with Bone Cancer in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (11.76)29.6817
2010's12 (70.59)24.3611
2020's3 (17.65)2.80

Authors

AuthorsStudies
Jia, ML; Liu, SY; Liu, W; Yang, H; Zeng, XF; Zhang, W; Zhu, WT1
Chen, F; Pan, W; Xiao, X; Zhang, Y1
Ding, J; Hao, M; Li, M; Li, Y; Tang, Q; Wang, B; Xie, M; Zhu, H1
Chao, SC; Chen, YJ; Huang, KH; Huang, KY; Kuo, KL; Liu, SH; Tang, CH; Wang, CC; Yang, RS; Yang, TH1
Ding, J; Jiao, M; Liang, J; Liu, T; Tang, Q; Wu, J; Zhu, H1
Chen, G; Xia, H; Yu, HL; Zhang, ZG1
Constandil, L; Flores, C; Hernandez, A; Kogan, MJ; Lespay-Rebolledo, C; Lobos, N; Lux, S; Pelissier, T; Pinto, M; Salas-Huenuleo, E1
Gweon, EJ; Kim, SJ1
Cheng, W; Fan, Q; Li, J; Liu, H; Lu, FF; Yan, CD; Yin, Q; Zhao, Y1
Chien, MH; Hsiao, M; Hsieh, FK; Lee, WJ; Tan, P; Tang, CH; Yang, SF1
Beck, JF; Becker, S; Blümel, L; Blumrich, A; Kahl, M; Krämer, OH; Siranjeevi, PM; Sonnemann, J; Winkler, R; Wittig, S1
Cheng, Z; Dai, W; Deng, X; Han, Y; Hu, L; Jiang, C; Li, F; Liu, W; Pan, C; Song, H; Wu, X; Yang, Y; Zhang, G1
Jiang, D; Yang, J; Zou, Y1
Cai, N; Chen, H; Jin, H; Li, B; Pan, J; Yu, K; Zhang, J1
Castillo-Pichardo, L; Cubano, LA; Dharmawardhane, S; Martínez, JE; Martínez-Montemayor, MM; Wall, KM1
Chen, D; Cole, B; Cs-Szabo, G; Ellman, MB; Im, HJ; Kc, R; Kim, J; Li, X; Stein, GS; van Wijnen, AJ; Yan, D1
Alkhalaf, M; Jaffal, S1

Reviews

1 review(s) available for resveratrol and Bone Cancer

ArticleYear
Resveratrol in management of bone and spinal cancers.
    Natural product research, 2019, Volume: 33, Issue:4

    Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Humans; Osteosarcoma; Resveratrol; Sarcoma, Ewing

2019

Other Studies

16 other study(ies) available for resveratrol and Bone Cancer

ArticleYear
Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/STAT3 Pathway.
    International journal of nanomedicine, 2023, Volume: 18

    Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Folic Acid; Humans; Janus Kinase 2; Lipopolysaccharides; Liposomes; Lung Neoplasms; Mice; Osteosarcoma; Resveratrol; STAT3 Transcription Factor

2023
miR-139-mediated NOTCH1 regulation is crucial for the inhibition of osteosarcoma progression caused by resveratrol.
    Life sciences, 2020, Feb-01, Volume: 242

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; MicroRNAs; Osteosarcoma; Real-Time Polymerase Chain Reaction; Receptor, Notch1; Resveratrol; Signal Transduction

2020
Resveratrol suppresses bone cancer pain in rats by attenuating inflammatory responses through the AMPK/Drp1 signaling.
    Acta biochimica et biophysica Sinica, 2020, Mar-18, Volume: 52, Issue:3

    Topics: AMP-Activated Protein Kinases; Animals; Astrocytes; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Dynamins; Female; Hyperalgesia; Inflammation; Mitochondria; Mitochondrial Dynamics; Osteosarcoma; Pain; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Spinal Cord

2020
Induction of sirtuin-1 signaling by resveratrol induces human chondrosarcoma cell apoptosis and exhibits antitumor activity.
    Scientific reports, 2017, 06-09, Volume: 7, Issue:1

    Topics: Acetylation; Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chondrosarcoma; Disease Progression; eIF-2 Kinase; Gene Expression Regulation, Neoplastic; Humans; Mice; Resveratrol; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Xenograft Model Antitumor Assays

2017
Resveratrol attenuates bone cancer pain through regulating the expression levels of ASIC3 and activating cell autophagy.
    Acta biochimica et biophysica Sinica, 2017, Nov-01, Volume: 49, Issue:11

    Topics: Acid Sensing Ion Channels; AMP-Activated Protein Kinases; Animals; Autophagy; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Female; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes

2017
The antinociceptive effect of resveratrol in bone cancer pain is inhibited by the Silent Information Regulator 1 inhibitor selisistat.
    The Journal of pharmacy and pharmacology, 2019, Volume: 71, Issue:5

    Topics: Analgesics; Animals; Behavior, Animal; Bone Neoplasms; Cancer Pain; Carbazoles; Cell Line, Tumor; Disease Models, Animal; Hyperalgesia; Male; Mice; Mice, Inbred BALB C; Resveratrol; Sirtuin 1

2019
Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways.
    Oncology reports, 2014, Volume: 32, Issue:1

    Topics: Anthracenes; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Chondrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Pyridines; Resveratrol; Stilbenes

2014
Resveratrol attenuates bone cancer pain through the inhibition of spinal glial activation and CX3CR1 upregulation.
    Fundamental & clinical pharmacology, 2014, Volume: 28, Issue:6

    Topics: Analgesics; Animals; Bone Neoplasms; CX3C Chemokine Receptor 1; Hyperalgesia; Injections, Spinal; Neuroglia; Pain; Rats; Rats, Sprague-Dawley; Receptors, Chemokine; Resveratrol; Stilbenes; Up-Regulation

2014
Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas.
    Oncotarget, 2015, Feb-20, Volume: 6, Issue:5

    Topics: 3' Untranslated Regions; Adult; Animals; Antineoplastic Agents; Binding Sites; Bone Neoplasms; Cell Line, Tumor; Cell Movement; CREB-Binding Protein; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Mice, SCID; MicroRNAs; Neoplasm Invasiveness; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Resveratrol; Signal Transduction; Stilbenes; Time Factors; Transcription, Genetic; Transfection; Xenograft Model Antitumor Assays; Young Adult

2015
Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
    Journal of cancer research and clinical oncology, 2016, Volume: 142, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Caspases; Cell Proliferation; Etoposide; Flow Cytometry; Heterocyclic Compounds, 4 or More Rings; Humans; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma, Ewing; Sirtuin 1; Stilbenes; Tumor Cells, Cultured; Vincristine

2016
Activation of Adenosine Monophosphate-activated Protein Kinase Suppresses Neuroinflammation and Ameliorates Bone Cancer Pain: Involvement of Inhibition on Mitogen-activated Protein Kinase.
    Anesthesiology, 2015, Volume: 123, Issue:5

    Topics: AMP-Activated Protein Kinases; Animals; Bone Neoplasms; Cell Line, Tumor; Female; Humans; Inflammation; Mitogen-Activated Protein Kinases; Pain; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes

2015
Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells.
    Molecular medicine reports, 2015, Volume: 12, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Osteosarcoma; Resveratrol; Stilbenes; Wnt Signaling Pathway

2015
Resveratrol inhibits phosphorylation within the signal transduction and activator of transcription 3 signaling pathway by activating sirtuin 1 in SW1353 chondrosarcoma cells.
    Molecular medicine reports, 2016, Volume: 14, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chondrosarcoma; Dose-Response Relationship, Drug; Humans; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Signal Transduction; Sirtuin 1; STAT3 Transcription Factor; Stilbenes

2016
Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols.
    Clinical & experimental metastasis, 2009, Volume: 26, Issue:6

    Topics: Animals; Apoptosis; Bone Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans; Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Mice; NF-kappa B; Quercetin; Resveratrol; Stilbenes; Vitis

2009
Biological effects of the plant-derived polyphenol resveratrol in human articular cartilage and chondrosarcoma cells.
    Journal of cellular physiology, 2012, Volume: 227, Issue:10

    Topics: Apoptosis; Bone Morphogenetic Protein 7; Bone Neoplasms; Cartilage, Articular; Cell Line, Tumor; Chondrocytes; Chondrosarcoma; Cytokines; DNA-Binding Proteins; Extracellular Signal-Regulated MAP Kinases; Humans; Inflammation; Interleukin-1beta; Metabolism; Oncogene Protein v-akt; Peptide Hydrolases; Plants; Polyphenols; Proteasome Endopeptidase Complex; Proteins; Resveratrol; Signal Transduction; Stilbenes; Transcription Factors

2012
Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: Novel cellular mechanisms involving the ERKs/p53 cascade.
    Free radical biology & medicine, 2006, Jul-15, Volume: 41, Issue:2

    Topics: Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Humans; Osteosarcoma; Poly(ADP-ribose) Polymerases; Resveratrol; Stilbenes; Tumor Suppressor Protein p53

2006